Polyestradiol Phosphate
drugOn this page
Also known as Estradiol phosphate polymerEstradurinFosfato de poliestradiolLEO 114LEO-114Phosphate de polyestradiolPolyest phosPolyestradiol phos phosphate
Summary
Polyestradiol Phosphate (CHEMBL1201477) is an approved small molecule (ATC L02AA02); indicated across 1 condition including neoplasm.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Small molecule
- ATC class: L02AA02
- Indications: 1 condition
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201477 |
| Name | Polyestradiol Phosphate |
| Type | Small molecule |
| Max phase | 4 |
| ATC | L02AA02 |
Also known as: Estradiol phosphate polymer, Estradurin, Fosfato de poliestradiol, LEO 114, LEO-114, Phosphate de polyestradiol, Polyest phos, Polyestradiol phos phosphate, Polyestradiol phosphate, POLYESTRADIOL PHOSPHATE
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
1 indication (1 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| neoplasm | 4 | MONDO:0005070 | EFO:0000616 |
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: neoplasm